Avid Radiopharmaceuticals Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $896M

Avid Radiopharmaceuticals General Information

Description

Developer of molecular imaging compounds intended for detecting and monitoring chronic human diseases. The company offers Amyvid, an imaging tool for positron emission tomography imaging of beta-amyloid plaque in the brain.

Contact Information

Website
www.avidrp.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 3711 Market Street
  • Seventh Floor
  • Philadelphia, PA 19104
  • United States
+1 (215)
Primary Industry
Discovery Tools (Healthcare)
Acquirer
Corporate Office
  • 3711 Market Street
  • Seventh Floor
  • Philadelphia, PA 19104
  • United States
+1 (215)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Avid Radiopharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 20-Dec-2010 $896M Completed Generating Revenue
6. Later Stage VC (Series D2) 21-May-2009 Completed Generating Revenue
5. Later Stage VC (Series C) 09-May-2007 Completed Generating Revenue
4. Early Stage VC (Series B) 05-Jan-2006 Completed Generating Revenue
3. Early Stage VC 14-Dec-2005 Completed Generating Revenue
2. Early Stage VC (Series A) 02-Dec-2005 $3.9M $4.4M Completed Product Development
1. Seed Round 05-Aug-2005 $500K $500K Completed Startup
To view Avid Radiopharmaceuticals’s complete valuation and funding history, request access »

Avid Radiopharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D2
Series D1
Series D
Series C
Series B 1,448,473 $0.001000 10% $3.46 $3.46 1x $3.46 5.49%
Series A 2,673,073 $0.001000 10% $1.46 $1.46 1x $1.46 10.13%
To view Avid Radiopharmaceuticals’s complete cap table history, request access »

Avid Radiopharmaceuticals Patents

Avid Radiopharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2016065145-A2 Psma targeted reversed carbamates and methods of use thereof Inactive 22-Oct-2014
WO-2016065145-A3 Psma targeted reversed carbamates and methods of use thereof Inactive 22-Oct-2014
US-20120251448-A1 Compounds for use in the detection of neurodegenerative diseases Inactive 03-Mar-2011
JP-2012514007-A Synthesis of 18f-radiolabeled styrylpyridine and its stable pharmaceutical composition from tosylate precursor Active 31-Dec-2008
JP-5717650-B2 Synthesis of 18f-radiolabeled styrylpyridine and its stable pharmaceutical composition from tosylate precursor Active 31-Dec-2008 A61K51/0455
To view Avid Radiopharmaceuticals’s complete patent history, request access »

Avid Radiopharmaceuticals Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
AllianceBernstein Asset Manager Minority
Alta Partners Venture Capital Minority
BioAdvance Capital (Conshohocken) Venture Capital Minority
Lilly Ventures Corporate Venture Capital Minority
Osage University Partners Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Avid Radiopharmaceuticals FAQs

  • When was Avid Radiopharmaceuticals founded?

    Avid Radiopharmaceuticals was founded in 2004.

  • Where is Avid Radiopharmaceuticals headquartered?

    Avid Radiopharmaceuticals is headquartered in Philadelphia, PA.

  • What industry is Avid Radiopharmaceuticals in?

    Avid Radiopharmaceuticals’s primary industry is Discovery Tools (Healthcare).

  • Is Avid Radiopharmaceuticals a private or public company?

    Avid Radiopharmaceuticals is a Private company.

  • What is the current valuation of Avid Radiopharmaceuticals?

    The current valuation of Avid Radiopharmaceuticals is .

  • What is Avid Radiopharmaceuticals’s current revenue?

    The current revenue for Avid Radiopharmaceuticals is .

  • How much funding has Avid Radiopharmaceuticals raised over time?

    Avid Radiopharmaceuticals has raised $72.5M.

  • Who are Avid Radiopharmaceuticals’s investors?

    AllianceBernstein, Alta Partners, BioAdvance Capital (Conshohocken), Lilly Ventures, and Osage University Partners are 5 of 8 investors who have invested in Avid Radiopharmaceuticals.

  • When was Avid Radiopharmaceuticals acquired?

    Avid Radiopharmaceuticals was acquired on 20-Dec-2010.

  • Who acquired Avid Radiopharmaceuticals?

    Avid Radiopharmaceuticals was acquired by Lilly USA.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process